NCT03782974View on ClinicalTrials.gov

A Follow-up Trial of Proglucamune® in the Treatment of Protective Qi Deficiency, a TCM Condition

NACompletedINTERVENTIONAL

Enrollment

207

Participants

Timeline

Start Date

January 6, 2019

Primary Completion Date

June 6, 2019

Study Completion Date

June 6, 2019

Conditions

Protective Qi Insufficiency (a Condition Term From TCM)

Interventions

DIETARY_SUPPLEMENT

beta glucan

Following screening and enrollment, participants will be treated with 2 tablets (Proglucamune or placebo) per day for a total duration of 8 weeks. Each Proglucamune tablet contained \~100 mg ß-glucan derived from Baker's Yeast extract (Saccharomyces cerevisiae, cell wall), Reishi mushroom powder (Ganoderma lucidum), and Shitake mushroom powder (Lentinula edodes).

Trial Locations (1)

L3R 5V6

Elegant And Olive Health Clinic, Markham

All Listed Sponsors

collaborator

Elegant And Olive Health Clinic, Canada

OTHER

lead

USANA Health Sciences

INDUSTRY

NCT03782974 - A Follow-up Trial of Proglucamune® in the Treatment of Protective Qi Deficiency, a TCM Condition | Biotech Hunter | Biotech Hunter